Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
Yoshihito Shima18
Japon Sauf Yoshihito Shima" 987
Yoshihito Shima Sauf Japon" 2
Japon Et Yoshihito Shima 16
Japon Ou Yoshihito Shima 1005
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000767 Yoshihito Shima [Japon]The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis.
000F93 Yoshihito Shima [Japon] ; Yasushi Kawaguchi [Japon] ; Masataka Kuwana [Japon]Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy.
001A11 Takayoshi Morita [Japon] ; Yoshihito Shima [Japon] ; James Badger Wing [Japon] ; Shimon Sakaguchi [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
002026 Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
003548 Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio TanakaA case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
003867 Yoshihito Shima [Japon] ; Tetsuya Tomita ; Taeko Ishii ; Atsuyoshi Morishima ; Yuichi Maeda ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio TanakaTocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis.
003888 Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio TanakaSuccessful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
003A05 Atsushi Ogata [Japon] ; Atsuyoshi Morishima [Japon] ; Toru Hirano [Japon] ; Yoshihiro Hishitani [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Toshio Tanaka [Japon]Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
003A38 Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
003B72 Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon]Therapeutic effect of tocilizumab on two patients with polymyositis
003C43 Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio TanakaMinimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
003C90 Yoshihito Shima [Japon] ; Yusuke Kuwahara [Japon] ; Hiroyuki Murota [Japon] ; Shun Kitaba [Japon] ; Mari Kawai [Japon] ; Toru Hirano [Japon] ; Junsuke Arimitsu [Japon] ; Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Atsushi Ogata [Japon] ; Ichiro Katayama [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon]The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
003E63 Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon]Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab
003F01 Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoSuccessful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
003F40 Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon]Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab
004045 Toshio Tanaka [Japon] ; Yusuke Kuwahara [Japon] ; Yoshihito Shima [Japon] ; Toru Hirano [Japon] ; Mari Kawai [Japon] ; Masako Ogawa [Japon] ; Junsuke Arimitsu [Japon] ; Keisuke Hagihara [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon]Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021